M&T Bank Corp Has $20.18 Million Position in Healthpeak Properties, Inc. (NYSE:DOC)

M&T Bank Corp reduced its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 995,537 shares of the real estate investment trust’s stock after selling 9,962 shares during the period. M&T Bank Corp owned 0.14% of Healthpeak Properties worth $20,180,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Avior Wealth Management LLC acquired a new position in shares of Healthpeak Properties in the third quarter valued at $37,000. Wiser Advisor Group LLC acquired a new position in shares of Healthpeak Properties in the third quarter valued at $42,000. Capital Performance Advisors LLP acquired a new position in shares of Healthpeak Properties in the third quarter valued at $42,000. Continuum Advisory LLC acquired a new position in shares of Healthpeak Properties in the third quarter valued at $44,000. Finally, AdvisorNet Financial Inc increased its holdings in shares of Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 563 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective on the stock in a report on Wednesday, January 15th. Robert W. Baird decreased their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Wedbush decreased their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Scotiabank decreased their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research note on Friday, February 28th. Finally, Wells Fargo & Company decreased their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. One analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Trading Up 1.0 %

Shares of Healthpeak Properties stock opened at $20.45 on Thursday. The company has a market capitalization of $14.30 billion, a price-to-earnings ratio of 58.42, a PEG ratio of 2.17 and a beta of 1.15. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. Healthpeak Properties, Inc. has a 12-month low of $16.66 and a 12-month high of $23.26. The firm’s 50-day moving average price is $20.19 and its two-hundred day moving average price is $21.32.

Healthpeak Properties Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a $0.305 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a dividend yield of 5.97%. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s dividend payout ratio is 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.